Search

Gastrostomy is an enteral nutrition option. Indications for its placement are diverse, among them, the alteration in the mechanics of swallowing, frequently present in patients with neurological diseases. Nutritional recovery is the objective in these patients evaluating the nutritional status after the placement of a PEG in the pediatric population. This is a retrospective cohort conducted to evaluate nutritional recovery in pediatric patients with PEG placement. It was performed using anthropometric and biochemical parameters before and after placement. Forty-seven subjects were included, from which weight, height, and upper arm circumference were obtained, to evaluate nutritional recovery using BMI or W/L according to age. Significant nutritional improvement was demonstrated in a population of 39 patients, who had a mean follow-up of 7 months. In our population, PEG is an enteral nutrition strategy that has a significant positive impact on nutritional status in a mean of 7 months after its placement. Therefore, considering the evolution time of these patients will guide the clinician in making decisions regarding surveillance and monitoring parameters of the nutritional status.

La desnutrición se define como aquella condición patológica, inespecífica, sistémica y potencialmente reversible que resulta de la deficiente utilización de los nutrimientos por las células de los organismos.1 De acuerdo con la Sociedad Americana de Nutrición Enteral y Parenteral (ASPEN, por sus siglas en inglés) se precisa como un desequilibrio entre el requerimiento y gasto energético, lo cual resulta en un déficit acumulativo de energía, proteína o micronutrientes que afectan de forma negativa el crecimiento, desarrollo y otros resultados relevantes en la población pediátrica. En cuanto a su severidad, de acuerdo con la Organización Mundial de la Salud (OMS), se clasifica según su puntuación Z en leve, moderada y severa.2

Paciente con sindrome de Down referido a nuestro departamento con cianosis y soplo cardiaco. Un ecocardiograma transtoracico mostro anomalia de Ebstein. Esta asociacion es extremadamente rara. Se inicio manejo medico ya que la lesion en la valvula tricuspide era leve. De acuerdo con nuestra revision, se han descrito unicamente 12 casos en literatura medica

Metabolic syndrome (MetS) and diabetes mellitus (DM) have become over the past years a global burden of disease. They are one of the main risk factors for cardiovascular disease among others. CVDs represent the number one cause of death globally. Diabetes Mellitus’ prevalence, especially type 2, has increased dramatically in a short period increasing health care costs and mortality worldwide. Detecting coronary artery disease in diabetic patients with a myocardial perfusion imaging method such as PET/CT is the primary concern for this review. The most recent survey in Mexico done in 2012 reveals that an overall prevalence of 9.4% of the population has DM, which is roughly 6.4 million people with DM. Myocardial perfusion imaging with PET/CT has proven to be an accurate method to assess myocardial perfusion defects and viability in both symptomatic and asymptomatic patients with DM. In this review, we briefly describe the latest data on DM in Mexico and the use of MPI with PET/CT for patients with this disease, creating a discussion of the use of this technique as a screening method for endothelial dysfunction to prevent cardiovascular outcomes.